FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Ban Skin Shock Devices: 29 Associations

Some 29 advocacy groups call on FDA to act quickly to finalize a ban on electric skin shock devices used to treat self-injurious or aggressive behavio...

latest-news-card-1
Human Drugs

CGMP Violations at Thailands S&J International

FDA warns Thailands S&J International Enterprises about CGMP violations in its production of finished drugs and refusing to allow some records to be c...

latest-news-card-1
Human Drugs

Court Orders FDA Hetlioz Action

The DC federal court orders FDA to act on a Vanda sNDA for a Hetlioz indication to treat jet lag disorder or schedule a hearing on the submission.

latest-news-card-1
Biologics

CAR T-Cell Development Considerations Guide

FDA posts a guidance entitled Considerations for the Development of Chimeric Antigen Receptor T Cell Products.

latest-news-card-1
Human Drugs

Guide on Race/Ethnicity Data Reporting

FDA releases a draft guidance entitled Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Product...

latest-news-card-1
Federal Register

Remote Regulatory Assessments Q&A Guide

Federal Register notice: FDA makes available a revised draft guidance entitled Conducting Remote Regulatory Assessments Question and Answers.

latest-news-card-1
Federal Register

Safety Surveillance Best Practices Document

Federal Register notice: FDA makes available a final document entitled Best Practices for FDA Staff in the Postmarketing Safety Surveillance of Human ...

latest-news-card-1
Human Drugs

Paxlovid EUA Modified to Move to NDA Product

FDA says that beginning 3/8, Pfizers Paxlovid that is labeled under a 12/2021 emergency use authorization will no longer be authorized for adults, and...

latest-news-card-1
Human Drugs

Senator Targets Firms Over Improper Patents

U.S. Senator Tammy Baldwin (D-WI) writes the four biggest drug companies marketing asthma inhalers urging them to stop unfairly blocking generics from...

latest-news-card-1
Human Drugs

Positive Data in Keytruda Kidney Cancer Trial

Merck says its Phase 3 KEYNOTE-564 trial evaluating Keytruda (pembrolizumab) as an adjuvant treatment in patients with renal cell carcinoma saw an imp...